Beijing Institutes

Featured in: Favicon

frontiersin.org Favicon

biomedcentral.com (+2) Favicon

science.org Favicon

thelancet.com Favicon

biorxiv.org Favicon

onlinelibrary.wiley.com Favicon

Articles

Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection

Aug 14, 2023 | thelancet.com | Cheeloo College |Beijing Institutes |George F. Gao

1Xu K Fan C Han Y Dai L Gao GF Immunogenicity, efficacy and safety of COVID-19 vaccines: an update of data published by 31 December 2021. Int Immunol. 34: 595-607 and the protein subunit vaccine ZF2001 (Anhui Zhifei Longcom, Hefei, China)2Dai L Gao L Tao L et al. Efficacy and safety of the RBD-dimer-based COVID-19 vaccine ZF2001 in adults. N Engl J Med.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →